ArticleThe European respiratory journal2022

Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study.

Akshay N Gupte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.